Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Acute coronary syndromes in 2013

Optimizing revascularization strategies in patients with ACS

Catheter-based revascularization has emerged as the gold-standard therapy for most patients with acute coronary syndromes (ACS). Optimizing outcomes in these patients requires appropriate adjunctive pharmacological therapy and percutaneous coronary intervention. Five studies published in 2013 are expected to have a major effect on treatment and prognosis of patients with ACS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Keeley, E. C., Boura, J. A. & Grines, C. L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 361, 13–20 (2003).

    Article  Google Scholar 

  2. Armstrong, P. W. et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N. Engl. J. Med. 368, 1379–1387 (2013).

    Article  Google Scholar 

  3. Bhatt, D. L. et al. Effect of platelet inhibition with cangrelor during PCI on ischemic events. N. Engl. J. Med. 368, 1303–1313 (2013).

  4. Stone, G. W. et al. Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 377, 2193–2204 (2011).

    Article  CAS  Google Scholar 

  5. Steg, P. G. et al. Bivalirudin started during emergency transport for primary PCI. N. Engl. J. Med. 369, 2207–2217 (2013).

    Article  CAS  Google Scholar 

  6. Kumbhani, D. J., Bavry, A. A., Desai, M. Y., Bangalore, S. & Bhatt, D. L. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: an updated meta-analysis of randomized trials. J. Am. Coll. Cardiol. 62, 1409–1418 (2013).

    Article  Google Scholar 

  7. Fröbert, O. et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N. Engl. J. Med. 369, 1587–1597 (2013).

    Article  Google Scholar 

  8. Kornowski, R. et al. Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. J. Am. Coll. Cardiol. 58, 704–711 (2011).

    Article  Google Scholar 

  9. Stone, G. W. et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364, 226–235 (2011).

    Article  CAS  Google Scholar 

  10. Wald, D. S. et al. Randomized trial of preventive angioplasty in myocardial infarction. N. Engl. J. Med. 369, 1115–1123 (2013).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregg W. Stone.

Ethics declarations

Competing interests

G. W. Stone has acted as a Consultant for Boston Scientific, Daiichi Sankyo and Eli Lilly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stone, G. Optimizing revascularization strategies in patients with ACS. Nat Rev Cardiol 11, 67–68 (2014). https://doi.org/10.1038/nrcardio.2013.214

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2013.214

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing